Results for tag: "Dermal Erythema Drug"

The Dermal Erythema Drug market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin conditions. Dermal Erythema Drugs are used to treat skin redness, inflammation, and irritation caused by a variety of conditions, including eczema, psoriasis, and rosacea. These drugs are available in a variety of forms, including topical creams, ointments, and oral medications. Common active ingredients in Dermal Erythema Drugs include corticosteroids, calcineurin inhibitors, and retinoids. Some companies in the Dermal Erythema Drug market include GlaxoSmithKline, Pfizer, Novartis, and Johnson & Johnson. Other companies include Bayer, Sanofi, and Allergan. Show Less Read more